Aigen Investment Management, LP Bausch Health Companies Inc. Transaction History
Aigen Investment Management, LP
- $597 Million
- Q3 2025
A detailed history of Aigen Investment Management, LP transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Aigen Investment Management, LP holds 38,660 shares of BHC stock, worth $242,784. This represents 0.04% of its overall portfolio holdings.
Number of Shares
38,660
Previous 13,121
194.64%
Holding current value
$242,784
Previous $84,000
196.43%
% of portfolio
0.04%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding BHC
# of Institutions
261Shares Held
242MCall Options Held
2.54MPut Options Held
6.46M-
John Paulson Paulson & Co. Inc. | New York, Ny70.8MShares$444 Million16.32% of portfolio
-
Goldentree Asset Management LP New York, NY34.8MShares$219 Million23.74% of portfolio
-
Nomura Holdings Inc Tokyo, M015.7MShares$98.6 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$81.6 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$76.9 Million0.0% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.27B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...